Valeant Pharmaceuticals Intl Inc VRX shares are trading higher by $0.80 (4.8 percent) at $16.78 in Wednesday's session. The issue is in the green for the second day in a row, rallying from Monday's close ($14.97) to its current level.
Bill Ackman's Pershing Square in December trimmed their stake by 3 million shares, which came to light in the firm's 13F on Tuesday.
It should be noted Ackman has held a majority of his stake since the stock plunged from its all-time high ($263.81) made in August 2015.
Related Link: 13F Roundup: Apple, Bank Of America And Other Stocks Hedge Funds Love/Hate
After a flat open, Valeant's stock found support just under Tuesday's close ($15.98), reaching $15.77 before embarking on a rally. So far, it has reached $16.80 and isn't far off that level. That high comes in just above its January 11 high ($16.68), but is well shy of its January 10 high ($17.55).
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
